Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Brickell Biotech, Inc.

https://brickellbio.com/

Latest From Brickell Biotech, Inc.

Two New Vaccines To Join COVID Fight As China Ships Millions Overseas

CanSino's COVID-19 vaccine is on the cusp of a formal approval in China, as is another candidate from state-owned Sinopharm. Meanwhile, China is shipping millions of doses around the world.

China Coronavirus COVID-19

Coronavirus Update: EU Demands AstraZeneca Meets Its Vaccines Commitments After Supply Warning

Plus Takeda starts vaccine trial in Japan and South Korea clears Celltrion's antibody therapeutic. 

Commercial Companies

China Sees No Variant Impact On Vaccines, Builds New mRNA Plant

Chinese officials do not expect the new strain of coronavirus emerging in the UK to impact the efficacy of inactivated virus vaccines on the cusp of conditional approval. Meanwhile, a new plant is under construction in China for domestically developed mRNA vaccines.

China Coronavirus COVID-19

Coronavirus Update: Moderna Snags Vaccine EUA

The FDA granted emergency authorization for Moderna's mRNA-1273 following a 17 December advisory committee vote in its favor. There have also been more supply deals and approvals in Asia.

Coronavirus COVID-19 Infectious Diseases
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Vical, Inc.
    • Vical Incorporated (VICL)
UsernamePublicRestriction

Register